About 10% of Americans Have Genes That May Make GLP-1 Drugs Less Effective: What You Should Know

Stanford found PAM gene variants in ~10% of people reduce GLP-1 drug effectiveness. Here’s why some Ozempic non-responders have a biology-based explanation — not a compliance problem.